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Bovine respiratory syncytial virus (BRSV) has been isolated in 
several parts of the world and has been found to be a major cause of 
bovine respiratory disease (1,2,3,4,5,6). The serological surveys that 
were done with these studies indicate that BRSV is widespread in many 
bovine populations. 
Serological surveys have been done using serum neutralization, 
plaque reduction, complement fixation or fluorescent antibody tests. 
Serum neutralization and plaque reduction are useful techniques, but 
they require several days to get results (1,2,3,4,5,6,7). The comple-
ment fixation (CF) test is quick and easy to perform, but details of 
the methods have not been described (1,8). A more recently developed 
test, that is sensitive and easy to perform, is the indirect fluorescent 
antibody (IFA) test (9). 
The serological studies done so far have been limited to random 
single samples of paired serum samples. This kind of testing has indi-
cated the incidence of BRSV and its role in respiratory disease out-
breaks, but has not given us much information about the antibody re-
sponse in cattle several months after infection. 
In the present study, the antibody response of naturally infected 
calves is followed through a four month period, using the IFA and CF 
test. Other objectives of this study were to determine the sensitivity 
l 
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of the IFA technique in performing BRSV virus titrations, and to evalu-




Respiratory syncytial virus (RS virus) is a virus of considerable 
importance in human medicine. Since its isolation in 1957, a consider-
able amount of research has been done with this virus and it is now 
known to be a major cause of human respiratory disease, particularly 
among infants and young children (10) . It was through research with 
human RS virus that the closely related bovine RS virus was discovered. 
The first evidence that a bovine RS virus might exist came in 1963. 
A group of researchers working with the RS virus realized that the calf 
serum used in their tissue culture medium was inhibiting syncytium pro-
duction that is characteristic of RSV. Further studies of different 
lots of calf serum established this inhibition to be caused by a specific 
antibody. This led them to the conclusion that a virus similar to the 
human RS virus must be present in cattle (11). 
Paccaud and Jaquier (1) reported the first isolation of BRSV from 
Swiss cattle in 1970. They reported on a respiratory disease outbreak 
that lasted 3 to 10 days. The cattle had upper respiratory tract symp-
toms, but several head later developed bronchopneumonia. They isolated 
a virus that was serologically related to RSV and they found serocon-
versions to the virus they isolated in several head of cattle using the 
complement fixation and serum neutralization tests. Their virus was 
also similar to RSV in its physicochemical properties. It was inacti-
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vated at low pH and at 56 C, but stable at -70 C and it was sensitive to 
lipid solvents and its size was between 0.22 u and 0.45 u. 
Bovine RS virus was next isolated in Japan during an outbreak of 
acute bovine respiratory disease. Inaba and coworkers (2) conducted a 
serological study and found BRSV to be the cause of this outbreak, and 
they also found their bovine RS virus to be serologically similar to 
RSV. In a later study (12), they found it contained RNA, was labile at 
56 C and 37 C, but stable at -80 C, and it was inactivated by trypsin 
and deoxycholate. 
-
Bovine RS virus was also isolated in 1970 during an outbreak in 
Belgium (3), and in England in 1971 (4). Forty percent of the Belgium 
cattle tested had neutralizing antibodies to BRSV, and they found that 
BRSV was the most common agent in respiratory disease in cattle during 
the cold months of the year (13,14). 
Berthiaume (8) tested sera from several species of animals in 
Canada by complement fixation. However, he did not give any details of 
his test methods. He suggested that sheep may make a good experimental 
model for studying BRSV. 
Smith (5) was the first to isolate BRSV in the United States. He 
isolated it from a herd of cattle in Iowa during an acute outbreak of 
respiratory disease. The most common symptoms were high rectal tempera-
tures and nasal discharges. His findings agreed with earlier reports 
that BRSV. is closely related to, but not identical to RSV, both serologi-
cally and in its physicochemical properties. His serological survey in-
dicated that exposure to BRSV was very common among Iowa cattle. 
Rosenquist (6) recovered a bovine RS virus at about the same time 
in Missouri from two calves with acute respiratory disease. He found 
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high convalescent, antibody titers to the viruses he isolated and he 
was also able to demonstrate cross neutralization with antiserum to the 
Long strain of RSV. 
Researchers in Alabama conducted a serological study to determine 
the prevalence of BRSV in that state (7). They found a positive neutra-
lizing titer to the Long strain of RSV in 60 percent of the adult healthy 
cattle they tested. They also found many seroconversions in three herds 
when these calves were exposed to other calves with respiratory disease. 
Most of the work done with BRSV has been done using the neutraliza-
tion test. However, Takahashi and coworkers (15) used the complement 
fixation test for detecting serum antibodies to BRSV. This required a 
modification of adding five percent normal calf serum to the complement 
diluent. They found a linear correlation between the complement fixation 
and neutralization tests. 
Potgieter {9) developed an indirect fluorescent antibody test for 
the diagnosis of BRSV. He was able to detect fluorescence at 48 hours 
and some fluorescence at 72 hours, but not at 96 hours after infection. 
Also he found antibody titers in some 67 percent of 400 bovine sera in 
Oklahoma cattle and commented that this technique was a rapid, sensitive 
and a relatively simple procedure to perform. 
In summary, BRSV has been found to be a major cause of bovine res-
spiratory disease in several countries. It is similar to, but not 
identical to, RSV and it contains RNA, is sensitive to lipid solvents 
and low pH, and its size is between 0.22 u and 0.45 u. Clinical symp-
toms vary from mild upper respiratory symptoms to severe bronchopneu-
monia. Cross reactivity has been demonstrated between RSV and BRSV by 
complement fixation and serum neutralization. This cross reactivity has 
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been used to demonstrate antibodies to BRSV by some researchers. A in-
direct f] uorescent ant.ibody method has also been used for detecting 
BRSV antibodies. Since it is a quick and simple procedure, it offers 
some advantages over the CF and neutralization tests. 
CHAPTER III 
MATERIALS AND METHODS 
Cell Cultures and Virus 
Cell Culture Technique 
The cell culture line used in all aspects of this project was a 
secondary culture of goat turbinate cell (GTU). The initiai culture was 
obtained at passage level ten from the Oklahoma Animal Disease Diagnostic 
Laboratory, Stillwater, Oklahoma, and turbinate cells from another goat 
were used in later aspects of the research beginning at passage level 
seven. 
These cells had been preserved in 7.5 percent dimethyl sulfoxide 
(DMSO) and stored in one ml aliquots at -70 C. The cells were used by 
rapidly thawing the vials at 37 C, then suspending the cells in ten ml 
of growth medium. The viable cells were allowed to attach overnight, 
then the medium was replaced with fresh growth medium. A~l the cells 
were grown in 75 cm2 or 25 cm2 plastic disposable tissue culture flasks 
(Corning Glass Works, Corning, N.Y.), and incubated at 37 C in a humid-
ified co2 incubator with five percent co2 . 
The growth medium used was Eagles basal medium with Earles salts 
and L-glutamine (BME/E). It was buffered with three ml of a 7.5 percent 
NaHC0 3 solution and supplemented with ten percent, irradiated, heat in-
activated, fetal bovine serum (Flow Laboratories, Rockville, Md.). The 
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cell cultures were maintained with BME/E medium supplemented with two 
percent fetal bovine serum. Cultures were generally kept antibiotic 
free, but when necessary, 50 to 100 ~g of gentamicin (Schering Corp., 
Kenilworth, N. J.) was added to the medium. The BME/E medium for cell 
cultures grown in microtiter plates and chamber/slides was supplemented 
with four percent fetal bovine serum and 100 ~g of gentamicin per ml of 
medium. 
When it was necessary to pass cells, the medium was removed from 
the flasks and the monolayers were rinsed three or four times with 
Rinaldini enzyme solution (R-saline) (16). The monolayers were then 
trypsinized with a 0.05 percent trypsin (Miles Laboratories, Inc., 
Elkhart, Ind.) solution. After the cells had loosened from the flask, 
the trypsin was neutralized with growth medium, then the cells were 
split 1:4 by passing cells into three new flasks and retaining the orig-
inal flask. To further remove the trypsin and non-viable cells, the 
medium was replaced with fresh growth medium the next day. 
Stock Virus 
The virus used was the FSl-1 strain of bovine respiratory syncytial 
virus (BRSV), obtained from, and originally isolated at Iowa State Uni-
versity (5). The virus had been passed several times in cell cultures 
containing antibodies to bovine diarrhea virus (BVD) and it was found to 
be free of BVD. 
Growth of Virus in Cell Cultures 
The GTU cells were infected either by passing the tissue culture 
medium from an infected flask to uninfected GTU cells, or the infected 
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cells were scraped loose, then the cells and medium were passed to unin-
fected GTU cells. 
The virus was harvested with the cells when the cells were showing 
75 percent or greater cytopathic effect (CPE). The cells were scraped 
from the surface with a sterile rubber police~an, then the virus was 
either passed to uninfected flasks or placed in sterile test tubes for 
storage. 
Virus intended for storage was preserved by adding autoclaved DMSO 
(Fisher Scientific Co., Fairlawn, N.J.) to the virus suspension. After 
the cells were scraped loose, enough DMSO was added to equal a final 
concentration of ten percent, and the virus divided into two ml aliquots 
and stored at -70 C. 
Virus Titrations 
Virus titrations were done using four and eight well chamber/slides 
(Lab-Tek Products, Miles Laboratories, Rockville, Md.). GTU cells were 
trypsinized and the cells were suspended in growth medium, then the 
cells were centrifuged and this medium was removed. The packed cells 
5 
were diluted with BME/E to contain approximately 2.7 x 10 cells per ml. 
Eight chambered slides were seeded with 0.2 or 0.15 ml of this cell sus-
pension and four chambered slides were seeded with 0.3 ml of cell sus-
pension. 
The virus was removed from storage at -70 C, and ten-fold dilutions 
of the virus was made in BME/E medium. Four wells of GTU cells were in-
fected, at the time of seeding, with either 0.1, 0.2 or 0.25 ml amounts 
of each virus dilution. With each titration, four chambers were left 
uninfected to serve as controls. The slides were incubated at 37 C in 
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a humidified co2 incubator (five percent C02 ) for 30, 72, 120 (five 
days), or 168 hours (seven days). For those slides incubated for five 
or seven days, the medium was changed on the third day of incubation. 
After incubation, the slides were fixed and stained either by a 
May-Grunwald-Giemsa (MG-G) method or an indirect fluorescent antibody 
(IFA) method. In one trial, the slides were first stained and examined 
by the IFA method then stained and examined by the MG-G method. 
The Reed-Muench (17) method, without summation, was used to calcu-
late the 50 percent tissue culture infective dose (TCID50). 
The May-Grunwald-Giemsa Staining Method 
The medium was removed and the cells were rinsed three times in R-
saline, then the cells were fixed for five minutes in absolute methanol. 
The plastic chambers were removed and the slides were covered with May-
Grunwald stain for ten minutes, followed by 20 minutes of staining with 
Giemsa stain. Next, the slides were rapidly dehydrated with two quick 
changes of acetone, then cleared with three changes of acetone-xylene, 
2:1; and three changes of acetone-xylene, 1:2. Finally the slides were 
covered with fresh xylene for ten minutes, then cover slips were mounted 
using permount. 
The slides were examined using the low and high dry objective of a 
light microscope. A chamber was considered infected if one or more 
syncytia (giant cells), containing three or more nuclei and cytoplasmic 
inclusions, were observed. 
Immunofluorescent Staining Method 
For those slides intended for immunofluorescent staining, the 
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plastic chambers were removed and the slides were rinsed in 0.01 M phos-
phate buffered saline (PBS), pH 7.5, then fixed in acetone for ten min-
utes at room temperature. After fixation the slides were stored at -70 
C until they were stained. 
A positive serum (from calf 115 of the C-8 project, March 8, 1976) 
and a negative serum (irradiated fetal bovine serum; Miles Laboratories, 
Rockville, Md.) were used for the initial step of the staining procedure. 
The positive serum was used to cover all the infected cells and two un-
infected wells, and the negative serum was used to cover the remaining 
two control wells. 
The cells were covered with a few drops of serum then incubated at 
37 C in a humidified chamber for 30 minutes. This was followed by 
rinsing 20 minutes in three changes of PBS and one change of distilled 
water, then the slides were allowed to partially dry at room tempera-
ture. Next, the cells were covered with rabbit, antibovine IgG, FITC 
conjugate (Miles Laboratories, Inc., Research Division, Elkhart, Ind.), 
diluted 1:8 in PBS. The cells were again incubated for 30 minutes at 
37 C in a humidified chamber, then rinsed and dried as before. Cover 
slips were then mounted using mounting fluid containing nine parts PBS 
and one part glycerol. 
The slides were then examined with a fluorescent microscope for 
the presence of specific, cytoplasmic fluorescence. A well was con-
sidered positive if at least on.e fluorescing cell was observed. 
Immunofluorescent Techniques 
Preparation of Chamber/Slides 
A modification of Potgieter's (18) method was used to prepare 
12 
chamber/slides. GTU cells from a 75 cm2 .tissue culture flask were tryp-
sinized and suspended in 15 ml of growth medium. Five ml of this sus-
pension was used to make four, eight or four chambered, chamber/slides. 
The cell suspension was placed in a sterile screwcap test tube, and 
centrifuged at 2000 rpm for five minutes. 
After centrifuging, the growth medium was removed and the cells re-
suspended in eight ml of BME/E (containing four percent fetal bovine 
serum and gentamicin), giving a cell suspension of approximately 2.5 x 
105 cells per ml. Two ml aliquots of virus, containing approximately 
104 I 1 · TCID50 m , were removed from storage and thawed, then mixed w1th the 
cell suspension. Eight chambered slides were inoculated with 0.3 ml of 
this suspension per chamber and four chambered slides were seeded with 
0.6 ml of the suspension per chamber. The slides were then incubated 
in a humidified co2 incubator at 37 C. 
At the end of 30 hours incubation, the slides were rinsed in 0.01 
M PBS and fixed in acetone for ten minutes. The slides were then stored 
at -70 C until needed. 
Preparation of Microtiter Plates 
Disposable, 96 well tissue culture, microtiter plates (Linbro 
Scientific Co. Inc., Hamden, Conn.) were also used in immunofluorescent 
studies. GTU cells were trypsinized and infected the same as the 
chamber/slides, then 0.1 ml of the cell suspension was added to each 
well of the plates. An additional 0.05 ml of medium was added to each 
well, then the plates were incubated in a co2 incubator at 37 C for 30 
hours. 
After incubation, the plates were fixed by the method outlined by 
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Pursell and Cole (19). The medium was aspirated off with a Pasteur 
pipet-suction flask apparatus and each well was rinsed with PBS, then 
one or two drops of PBS were added to each well and the wells were 
carefully filled approximately three-fourths full with acetone. Each 
well was allowed to fix in acetone at least ten minutes before the PBS-
acetone mixture was removed. The plates were then stored at -70 C un-
til they were stained. 
Antibody Titration and Fluorescent Staining 
Procedure 
Potgieter's (18) indirect immunofluorescent staining procedure was 
used for staining the chamber/slides and microtiter plates. The sera 
to be tested was initially screened at a 1:10 dilution in PBS, and posi-
tive sera were further tested at two-fold dilutions from 1:20 through 
1:640. 
The staining procedure was started by covering the cells with a 
few drops of serum dilution. The preparations were then incubated at 
37 C in a humidified chamber for 30 minutes. This was followed by 
rinsing 20 minutes with three changes of PBS and one change of distilled 
water, then the preparations were allowed to partially dry at room 
temperature. 
Next, the cells were covered with rabbit, anti-bovine IgG, FITC 
conjugate (Miles Laboratories, Inc., Research Division, Elkhart, Ind.), 
diluted 1:8 or 1:10 in PBS. The cells were again incubated for 30 
minutes at 37 C, followed by rinsing as before. The rinsing stages 
were done in coplin jars when slides were stained, and a Pasteur pipet-
suction flask apparatus was used to remove reagents with the microtiter 
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plates. 
The tissue culture plates were allowed to dry by inverting them on 
il pap<.'r towel. l•'or the chamber/slides, the rubber gaskets were removed 
and the slides were mounted with coverslips using a mounting fluid con-
taining nine parts PBS and one part glycerol. 
Each time the staining procedure was done, a negative control 
serum (irradiated, fetal bovine serum; Miles Laboratories, Rockville, 
Md.) and a positive control serum (calf 115 from the C-8 project, March 
8, 1976), diluted 1:10 in PBS, were included with the test. 
Microscopy and Photography 
The specimens were examined with transmitted light using a Lietz 
orthoplan microscope equipped with a dry darkfield condenser, a 150 watt 
high pressure xenon lamp, a LP 500 exciter filter and a K 510 barrier 
filter. 
This microscope was used with a X20, long working distance objec-
tive and a X25 and X40 objective with XlO occulars giving final magnifi-
cations of X200, X250 and X400, respectfully. The long working distance 
objective was used. to examine the microtiter plates and the other objec-
tives were used to examine the chamber/slides. 
Another microscope was used for photography and to examine some of 
the chamber/slides. This was a Carl Zeiss microscope equipped with epi 
illumination, a halogen lamp, and a 490-500 nanometer exciter filter 
and a 528 nanometer barrier filter. Two objectives, a X25 and a X40, 
were used with Xl2.5 occulars, giving final magnifications of X312.5 
and X500. 
The cells were examined for specific cytoplasmic fluorescence and 
15 
were considered positive if one or more fluorescing cells or syncytia 
were observed. At higher magnifications, this was observed as fluoresc-
inq particles, while at lower magnifications fluorescence was observed 
as complete or partial cytoplasmic fluorescence. 
Photographs were taken using a Carl Zeiss, 35 mm camera and ansa-
chrome (General Aniline Film Corp.) 500 ASA daylight color film. 
Complement Fixatio~ Techniques 
Preparation of Complement Fixation Antigens 
Two methods of preparing complement fixation antigens were used, 
one a whole culture antigen and the other a cellular antigen. 
The whole culture method used was that of Beem and Hamre (10). 
Monolayers of GTU cells were infected with the FSl-1 strain of bovine 
RS virus, then incubated at 37 C until the cells were showing 75 per-
cent or greater CPE. The remaining attached cells were scraped loose 
and the medium and cells were stored at -70 C, followed by several 
cycles of thawing at 37 C and freezing at -70 C. The medium was then 
centrifuged and the supernatant fluid retained as antigen. Antigen 
from several flasks were pooled and stored at -70 C. 
Modifications in this procedure were also used. The antigen was 
concentrated 1:10 using a Millipore Molecular Separator (Millipore 
Corp., Bedford, Mass.), and media from cells showing less than 75 per-
cent CPE were tested for CF antigens. 
The other method of preparing antigens was a modification of 
Schmidt and Lennettes' method (20). The antigen was produced the same 
as the whole culture antigen, but instead of immediately freezing the 
medium, it was centrifuged and the cellular portion was saved. Then 
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the cells were resuspended in R-saline to one tenth the original volume. 
The cells were frozen (-70 C) and thawed (37 C) several times, centri-
fuged, and the supernatant fluid was used as antigen. Antigen from 
several flasks were pooled and stored at -70 C until needed. 
The antigens were titrated by testing two-fold dilutions of antigen 
(1:2 to 1:64) against two-fold dilutions of antiserum (1:8 to 1:128). 
One unit of antigen was defined as the highest dilution of antigen show-
ing 75 percent or greater fixation with the highest dilution of serum. 
Four units, or four times the one unit dilution, .were used in the CF 
test (21). 
When anticomplementary activity was encountered with the antigens, 
they were treated with inactivated guinea pig serum (22). Guinea pig 
complement was inactivated at 56 C for 30 minutes, then it was added, at 
a 10 or 25 percent concentration to the antigen. The mixture was then 
incubated at 37 C for one hour, and the antigen titrations were repeated. 
The Complement Fixation Test 
The complement fixation (CF) test used was the microtiter method 
of Lennette's (21), except that the two percent sheep cell suspension 
was determined by centrifuging the cells rather than by using a spectro-
photometer. 
The sheep cells, hemolysin and complement were all obtained from 
commercial sources (Brown Laboratories, Topeka, Kan.; Microbiological 
Associates, Bethesda, Md.; and International Scientific Industries, 
Inc., Cary, Ill., respectfully). Also, commercially prepared CF rea-
gents for the Long strain of respiratory syncytial virus (Microbiologi-
cal Associates, Bethesda, Md.) were used. These included a positive 
serum (RSV antiserum, titer 1:64), a positive antigen (RSV antigen, 
titer 1:64), and a non-infected tissue culture control antigen. 
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The RSV antiserum was used as a positive control serum and fetal 
bovine serum (Flow Laboratories, Rockville, Md.) was used as a negative 
control serum. After titration, the RSV antigen was diluted to contain 
four units and was used in the CF test rather than the previously de-
scribed bovine virus antigens. 
The CF test was conducted using disposable "U" bottom plates 
(Linbro Scientific Co., Harnden, Conn.), 0.025 ml droppers (Flow Labora-
tories, Rockville, Md.), and 0.025 ml diluting loops (Baltimore Biolog-
ical Laboratories, Cockeysville, Md.). In determining the CF antibody 
titer, serum was diluted serially two-fold and 0.025 ml of four unit 
antigen was added to each dilution, Then 0.025 ml of complement (con-
taining two units) was added to each dilution and the plates were 
shaken then incubated overnight at 4 C. The next morning 0.05 ml of 
sensit.ized sheep cells was added to each well, then the plates were 
sealed with vinyl tape and incubated in a 37 C waterbath for 30 minutes. 
After incubation the plates were centifuged for ten minutes and 
examined. The antibody titer was expressed as the highest serum dilu-
tion showing 25 percent or less hemolysis. 
When bovine serum was being used in the antigen titrations or the 
CF test, a modifying factor was added to the complement diluent. Modi-
fier was also used in the complement titrations to account for any anti-
complementary effects of the modifier. This modifier was fresh normal 
bovine serum (obtained from the Oklahoma Animal Disease Diagnostic 
Laboratory, Stillwater, Okla.) and was added at a five percent concen-
tration to the complement diluent. 
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Anticomplementary serum was treated by adding 0.4 ml of serum to 
0.1 ml of guinea pig complement, and incubating at 37 C for 30 minutes, 
then the mixture was diluted in saline diluent. The serum was heat in-
activated at 56 C for 30 minutes, then retested (23). 
Serological Survey 
The serum samples tested were from 25 calves raised at the Veter-
inary Research Station at Pawhuska, Oklahoma. The calves were used in 
the C-8 bacterin experiment conducted by another research group (the 
Respiratory Disease Laboratory, Oklahoma State University), and the 
serum samples they collected were used in the present research with 
their permission. The calves were recently weaned, four to seven month 
old calves weighing 400 to 500 pounds. The experiment was conducted 
from November, 1975 through March, 1976, with serum specimens taken at 
approximately weekly intervals, and stored at 4 C. This experiment was 
divided into two parts referred. to as the Pawhuska and Stillwater phase. 
A protocol for this experiment is attached to the Appendix. 
CHAPTER IV 
RESULTS 
The results of the virus titration experiments are given in Table 
I. The sensitivity of an IFA titration method was determined by com-
paring this method to a MG-G titration method. 
In the first experiment, the IFA titration was incubated for 30 
hours and the MG-G titration was incubated for seven days (168 hours). 
At these incubation periods the IFA method was less sensitive (gave a 
lower titer) than the MG-G method. This was also the case in the second 
experiment when the same incubation times were used, but the size of the 
inoculum was increased from 0.1 ml to 0.25 ml. 
In the third experiment, 0.2 ml of virus inoculum was used, and 
IFA titrations incubated for 72 and 120 hours were compared to a MG-G 
titration incubated for 168 hours. Both the IFA titrations gave titers 
that were 0.5 log higher than the MG-G method. In this case the IFA 
method was not only a more sensitive method, it also required a shorter 
incubation period by 48 hours. 
In the last experiment, an attempt was made to eliminate any random 
variation between the two methods by first examining the slides by the 
IFA method, then restaining and examining these slides by the MG-G 
method. Two titrations were done using a 72 and a 120 hour incubation 
period. At 72 hours, the IFA method gave a slightly higher titer and 




SUMMARY OF VIRUS TITRATIONS 
Date: Date: 
2 
m1 of Hours 
. 3 
Harvest1 Titered Method Inoculum Incubation T1.ter 
Feb. 16 Apr. 9 MG-G 0.10 168 104.67 
Feb. 16 Apr. 9 IFA 0.10 30 104.5 
Apr. ll Apr. 25 MG-G 0.25 168 105.1 
Apr. ll Apr. 25 !FA 0.25 30 104.1 
Apr. 17 May 12 MG-G 0.20 168 104.2 
Apr. 17 May 12 IFA 0.20 72 104.7 
Apr. 17 May 12 IFA 0.20 120 104.7 
Apr. 24 May 23 MG-G 0.25 72 104.1 
Apr. 24 May 23 IFA 0.25 72 104.3 
Apr. 24 May 23 MG-G 0.25 120 104.3 
Apr. 24 May 23 IFA 0.25 120 104.3 
l 
Represents the date the virus was stored at -70 C. 
2MG-G = May-Grunwa1d-Giemsa technique: !FA = Indirect Immuno-
fluorescent Antibody Technique. 
3 
Expressed as Tcro50/ml. 
at 120 hours incubation. This again indicated that the IFA method was 
as sensitive as the MG-G method, but required two less days incubation 
than the MG-G method. 
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The results of these experiments indicate that the IFA method may 
be a more sensitive method of determining BRSV titers and it requires a 
shorter incubation time than the MG-G method. However, when IFA titra-
tions are done at 30 incubation, it is not as sensitive as MG-G titra-
tions done at seven days. 
Results of the fluorescent antibody titers are given in Tables II, 
III, and IV. All of these results were obtained by using microtiter 
tissue culture plates stained by an indirect fluorescent antibody pro-
cedure. 
Table II gives the range of antibody titers, and the degree of 
fluorescence, of 24 sera from the last part of the C-8 experiment. This 
information was used to determine a starting dilution and the range of 
antibody titers. Undiluted serum gave too much nonspecific fluorescence 
and the results at a 1:1000 dilution were either borderline or negative, 
so a 1:10 starting dilution was used and all positive sera were tested 
at two-fold dilutions from 1:20 through 1:640. 
The titers, and the degrees of fluorescence, of the Pawhuska and 
Stillwater sera are given in Tables II and III. Only one calf, number 
127, had an antibody titer at the beginning of the experiment, and 
another calf, number 105, had a borderline reaction at this time. All 
the calves began to show an antibody rise in one week and continued to 
show a rise until a titer of 1:640 was reached within the first month 
(December 11) by all the calves. The titers and the degree of fluores-

























RANGE OF FLUORESCENT ANTIBODY TITERS FROM C-8 
PROJECT USING MICROTITER PLATES 
Serum Dilutions 
Date Undiluted 10 100 
Mar. 8 4+1 4+ 2+ 
Mar. 8 3+ 2+ 1+ 
Mar. 8 3+ 2+ 1+ 
Mar. 8 4+ 2+ 1+ 
Mar. 8 3+ 2+ 2+ 
Mar. 8 3+ 2+ 2+ 
Mar. 8 3+ 2+ 1+ 
Mar. 8 2+ 1+ 1+ 
Mar. 8 4+ 3+ 2+ 
Mar. 8 3+ 2+ 2+ 
Mar. 8 3+ 2+ 2+ 
Mar. 8 4+ 3+ +/-
Mar. 8 2+ 2+ 1+ 
Mar. 8 3+ 2+ 1+ 
Feb. 10 3+ 2+ 1+ 
Feb. 10 3+ 3+ 2+ 
Feb. 10 3+ 3+ 2+ 
Feb. 10 3+ 2+ 2+ 
Feb. 10 4+ 1+ 
Feb. 23 3+ 2+ 1+ 
Feb. 23 3+ 3+ 2+ 









Degree of fluorescence; 4+, very strong; 3+, strong; 2+, moderate; 
1+, weak; +/-, b<=irder1ine; (-) , no fluorescence. 
TABLE III 
PAWHUSKA PROJECT ANTIBODY TITERS BY INDIRECT FLUORESCENT ANTIBODY TEST 
Calf No. Nov. 13 Nov. 20 Nov. 26 Dec. 4 Dec. 11 Dec. 18 Jan. 15 
Group I 
-1 
10(1+) 2 160(1+) 640(1+) 640(1+) 640(1+) 640(1+) 101 s -
102 s - 20(1+) 160(1+) 640(1+} 640(3+) 640(3+) 640(2+) 
103 s - 20(1+) 640(1+) 640(1+) 640(1+} 640(1+} 640(1+) 
104 c - 10(1+) 160(1+} 640(2+) 640(2+) 640(1+) 320(1+) 
105 c 10(+/-) 20(2+) 320(1+) 640 (1+) 320(1+) 320(1+) 160 (1+) 
Group II 
107 s - 20(1+) 160(1+) 320(1+) 640(1+) 320(1+) 320(1+) 
108 s - 40(1+) 640(1+) 640(1+) 640(2+) 640(2+) 640(1+) 
109 s - 20(1+) 160(1+) 320(3+) 640(2+) 640(1+) 640(1+) 
HOC - 40(1+) 160(1+) 640(1+) 640(1+) 640(2+) 640(1+) 
lllC - 10(1+) 640(2+) 640(3+) 640(2+) 640(2+) 640(2+) 
Group III 
113S - 20(1+) 320(2+) 320(2+) 640(3+) 640(2+) 640(1+) 
114S - 20(1+) 160(1+) 640(1+) 640(1+) 640(1+) 320(1+) 
ll5S - 10(1+) 320(1+) 640(2+) 640(2+) 640(1+) 640(1+) 
ll6C - 10(1+) 80 (1+) 80(1+) 640(1+) 640(1+) 320(1+) 





















































































2Reciprocal of antibody dilution. Parentheses indicates quantitative degree of fluorescence. 4+, very 



























STILLWATER PROJECT ANTIBODY TITERS BY INDIRECT 
FLUORESCENT ANTIBODY TEST 
Jan. 29 Feb. 10 Feb. 23 Mar. 8 
: 3201 320 320 
320 640 640 640 
320 640 320 160 
320 320 160 160 
160 640 320 320 
160 320 320 
640 160 80 80 
320 640 320 160 
320 640 640 
640 640 320 160 
320 160 640 640 
640 320 320 640 
640 640 640 640 
640 640 320 
320 320 640 
320 160 320 640 
320 320 320 640 










TABLE IV (Continued) 
Calf No. Jan. 29 Fc~b. 10 Feb. 23 Mar. 8 Mar. 16 
121 320 640 320 320 
125 640 640 640 640 
1Reciprocal of antibody dilution; all sera scored as 1+ degree of 
fluorescence. 
2 
N.T. = Not Tested; Blank spaces indicate that calves were notbled 
that day. 
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and January 15), however, the calves still retained high titers (1:80) 
through March. 
There was little variation noted between.each group or between the 
transported and the nontransported calves. The only difference was that 
during the Pawhuska phase of the experiment, the transported calves 
reached titers of 1:640 quicker and retained this titer longer than did 
the nontransported calves. All 16 of the transported calves had a titer 
of 1:640 at four weeks, but only eight of nine (89 percent) of the con-
trol group still had a 1:640 titer. Also, 13 shipped calves (81 percent) 
still had a 1:640 titer at eight weeks (January 15), compared to five 
calves (56 percent) of the nontransported calves. 
There also were no significant differences in antibody response 
between the groups in the Stillwater project. Calves aerosoled with 
BRSV or BRSV and Pasteurella multocida (groups III and IV) did not show 
marked increases in antibody titers, and some calves (103, 113 and 121) 
even showed a drop in titer. The groups not receiving BRSV (groups I 
and II) showed similar variation in antibody response. 
Table V gives a description of the various CF antigens used and 
Tables VI, VII and VIII give the results obtained with these antigens. 
Despite the fact that several attempts and several modifications were 
made, all the BRSV antigens tested were either anticomplementary (AC) 
or gave low antigen titers. 
The commercially prepared RSV antigen (Ag 1) gave the 1:8 titer 
specified by the manufacture when it was tested against their RSV anti-
serum. This antigen was then used to screen several bovine sera from 
the C-8 project. From this, two sera with the highest titers (referred 
to as bovine antiserum 114 and 115) were used in conjunction with the 
RSV antiserum to test the BRSV antigens. 
Figure 1. Specific Cytoplasmic Fluorescence 



























Commercially prepared CF antigen to the Long strainof 
Human RSV (minimum titer of 1:8) 
Antigen harvested at 75% or greater CPE 
Antigen harvested at 75% or greater CPE 
Medium from cells showing less than 25% CPE 
Medium from same cells as Ag 4, but at 50% CPE 
Medium from cells at 50% CPE 
Same cells as Ag 6, but harvest of cells and medium 
at 75% or grea,ter CPE 
Medium from cells showing less than 25% CPE 
Medium from cells showing less than 25% CPE 
Medium from cells showing 40-60% CPE 
Harvested medium and cells from Ag 10 at 75% or 
greater CPE 
Ag 11 concentrated lOX with a millipore separator 
Harvested medium and cells at 75% CPE, then concen-
trated lOX with a millipore separator 
Dialysate portion of Ag 13 
Antigen harvested at 75% or greater CPE 
Concentrated cell phase from Ag 15; cells resuspended 
at 1/10 volume in R-saline 
Fluid portion removed from Ag 16 when the cells were 
separated from the medium 
Pooled antigen (produced the same as Ag 16) 




























































1115 = Bovine serum from calf No. 115, C-8 project, serum drawn on 
March 8, 1976; a titer of 1:128 vs. antigen of Long strain of Human RSV. 
RSV = antiserum to the Long strain of respiratory syncytial virus; titer, 
1:64. 
2Ac indicates the antigen is anticomplementary; (-) indicates nega-
tive at a 1:2 dilution. 
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TABLE VII 




Ag 15 RSV 1:2 
Ag 16 RSV 1:4 
Ag 17 RSV 
Ag 101 RSV 1:4 
Ag 101 115 AC 
Ag 1012 114 AC 
Ag 1013 114 AC 
Ag 1014 115 AC5 
1Antiserum 114 from calf No. 114, C-8 project, March 16, 1976; a 
titer of 1:128.vs. antigen of Long strain of Human RSV. 
2Antigen titration done using modified Kolmer saline diluent. 
3Antigen titration done using LBCF veronal buffer diluent. 
4 
Both Ag 101 and antiserum 115 were treated for anticomplementary 
activity before use. 














COMPARISON OF TREATMENTS FOR ANTICOMELEMENTARY ANTIGEN 
WITH DIFFERENT LEVELS OF COMPLEMENT MODIFIER 




























Whole culture antigens, Ag 2 and Ag 3, gave titers of 1:4 with RSV 
antiserum, but were negative and AC, respectfully, when tested with 
bovine antiserum 115. Antigens four through ten, harvested at various 
stages of CPE, were either AC or negative when tested with bovine anti-
serum 115 or RSV antiserum. Antigen 11 gave a 1:2 titer verse RSV anti-
serum then it was concentrated lOX by vacuum dialysis (Ag 12). However, 
this did not increase the titer with either the RSV or 115 antiserum, 
and it was AC when retested with RSV antiserum. Another antigen, Ag 13, 
was concentrated but it was also anticomplementary with RSV antiserum, 
however, the dialysate of this antigen, Ag 14, did not contain CF anti-
gen. 
When the whole culture antigen (Ag 15), cell phase antigen (Ag 16) 
and the culture medium removed from the cell phase antigen (Ag 17) were 
tested with RSV antiserum the titers were 1:2, 1:4 and negative, re-
spectfully. This indicated that the CF antigen was only released after 
the cells were disrupted. When a pooled cell phase antigen (Ag 101) 
was tested with RSV antiserum, it again gave a 1:4 titer, but it was AC 
with both bovine antiserum 114 and 115. 
Several attempts were made to find the cause of the AC activity. 
A different diluent, verona! buffer (24) was tried and the antigen and 
antiserum were treated for anticomplementary activity. However, none 
of these changes solved the problem. 
An experiment was then done to test two types of AC treatment for 
antigens, using 0, 5, and 10 percent amounts of complement modifier 
(Table VIII) . Results from this experiment showed there was no differ-
ence between the two AC treatments, but the test was AC only when the 
complement modifier was present. 
Because of the problems encountered with BRSV antigens, attempts 
to use it were discontinued. Later it was decided to use the commer-
34 
cially prepared RSV antigen in the CF test. To overcome the AC activity 
of the complement modifier, the modifier was added to the complement 
diluent (at a five percent concentration) to perform the complement ti-
tration. This proved to be an effective method of eliminating the AC 
problems encountered previously. 
The sera from seven calves from the C-8 project, collected at four 
to six week intervals, were selected for the CF test. The antibody 
titers obtained with these sera are given in Table IX. All of the calves 
were negative at the beginning of the experiment, then showed a rapid 
rise to their highest titer at four weeks. The titers began to decrease 
after this but all the calves still had a 1:8 or greater titer in March. 
Calf 115, however, reached his highest titer both at four weeks and at 
sixteen weeks (March 8). 
Four of these calves had been transported during the Pawhuska ex-
periment (calves 102, 115, 120 and 123) and three of them (102, 115 and 
120) had higher titers than the nontransported calves at four weeks. 
Two of the control (105 and 127) reached a high titer of 1:32 and the 
third control calf (117) reached a high titer of 1:64 in four weeks. 
Also, four of the calves (102, 115, 120 and 123) were aerosoled 
with BRSV shortly after the January 29 bleeding, three of which showed 
a rise in titer or a steady titer five weeks later (March 8). The 
fourth calf (102), although not showing an antibody rise did retain a 
significant titer of 1:32 on March 8. Meanwhile, those calves notre-
ceiving BRSV (105, 117 and 127) showed steadily decreasing titers during 


















COMPLEMENT FIXATION ANTIBODY TITERS FROM THE C-8 PROJECT 









Pawhuska Phase (Nov. 13 - Dec. 11) Calf. No. 
PBS, transported 102 
PBS 105 
PBS, transported 115 
PBS 117 
Pasteurella Bacterin, transported 120 
Pasteurella Bacterin, transported 123 
Pasteurella Bacterin 127 








Stillwater Phase (Jan. 29 - Mar. 8) 
BRSV and Pasteurella multocida 
PBS 
BRSV and Pasteurella_multocida 
Pasteurella multocida 
BRSV and· Pasteurella multocida 
BRSV 
PBS 
;All sera were tested using four units of CF antigen to the Long strain of Human RSV. 




These results are in general agreement with the IFA titers, with 
the highest titers (or intensities of fluorescence) reached in four 
weeks, then the titers or fluorescence began to decrease. Significant 
titers were still evident, though, after sixteen weeks. The CF test 
was not as sensitive as the IFA test. It did not detect the positive 
serum (calf 127) or the borderline reaction (calf 105) on November 13, 
and the CF titers were considerably lower than the IFA titers. However, 
since the CF test was done using RSV antigen, these titers are probably 
lower than what would be found using a suitable BRSV antigen. 
CHAPTER V 
DISCUSSION 
The purpose of the virus titration experiments was to determine 
the usefulness of the IFA technique for titrating BRSV. To do this the 
IFA method was compared to a MG-G titration method. After several mod-
ifications were tried, it was found that under certain conditions the 
IFA method was as sensitive as the MG-G method, but required a shorter 
incubation period. 
Thirty hours incubation was chosen for the IFA procedure because 
this was thought to be the time of maximum fluorescence, and five to 
seven days is required for the MG-G method for complete development of 
CPE. However, the 30 hour incubation period was not the time of maxi-
mum fluorescence, since it was less sensitive than the MG-G method. 
This was true even when the virus inoculum was increased from 0.1 ml to 
0.25 ml. 
Because of this problem, attempts were made to increase the incu-
bation time for the IFA procedure. It was found that fluorescence 
could be detected at 30, 48, 96 and 120 hours, which was not in agree-
ment with previous research findings. Potgieter was able to detect 
slight fluorescence at 72 hours incubation, but no fluorescence at 96 
hours (9). Based on these findings, IFA titrations were incubated for 
72 and 120 hours. At these longer incubation periods, the IFA method 
was as sensitive or more sensitive than the MG-G titration method, but 
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the IFA titers could be determined two days earlier. 
The lower IFA titers at 30 hours incubation was not expected, since 
this is sufficient time to produce fluorescence when a larger inoculum 
is used. Random variation between the IFA and MG-G stained slides may 
have accounted for some or all of this difference. It is also possible 
that fluorescing cells were so few that they were not observed, or it 
may be that a larger virus inoculum is required to produce maximum 
fluorescence at 30 hours. 
The MG-G and IFA methods require about the same amount of time to 
perform and both are tedious, time consuming procedures requiring close 
examination of the cells. However, since an IFA method may give slight-
ly higher titers and requires a shorter incubation period, this method 
has an added advantage over the MG-G method. 
Another use of the IFA technique is in determining serum antibody 
titers. In the present study, when it was used in conjunction with 
microtiter tissue culture plates, it was found to be a rapid, inexpen-
sive method of determining antibody titers from a large number of 
samples. 
The C-8 project also offered an opportunity to apply the IFA tech-
nique to the diagnosis of BRSV infections. The results indicated that 
antibody titers may rise rapidly and high titers of 1:640 or greater 
are not uncommon. Also these high titers may be detected several months 
after the initial infection. This information may be useful in deter-
mining whether the antibodies are of natural or maternal origin and in 
determining the exact time of infection. 
Some researchers have suggested that calves may not become infected 
from their dams, but are infected after being commingled with different 
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groups of calves (18). Since these calves represent a closed herd, they 
must have been infected from their dams. Also, since most of the calves 
I 
were negative at the beginning of the experiment and all the calves 
showed a rise in titer, their antibodies must have been of natural 
origin. 
Why there was a rapid increase in antibodies during the first week 
of the experiment is uncertain. It is possible the virus was present in 
too low of a concentration to stimulate serum antibody production, but 
with the stress due to transportation and treatment, virus titers in-
creased enough to stimulate serum antibody production. Another explana-
tion may be that the IFA test is so sensitive that a moderate increase 
in antibody levels may mean a sharp increase in IFA antibody titers. 
This may also explain why antibody titers remained at such high levels 
throughout the experiment. 
The lack of significant difference between the four groups of the 
Pawhuska project may have been due to the design of the project. Since 
the calves were pastured together before and during the experiment, the 
virus had ample opportunity to spread through the herd. One difference 
that was observed was that most of the transported calves reached their 
highest titers sooner and retained these titers longer than the non-
transported calves. This may indicate that the stress of transportation 
affected the antibody response of the calves. 
There also was little difference noted between the groups of the 
Stillwater project, despite the fact that two of the groups (groups 
three and four) were aerosoled with bovine RS virus. A secondary re-
sponse may not have occurred because of too low of a virus dosage, or 
the secondary response may not have included serum IgG antibodies. 
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The use of microtiter tissue culture plates was also found to be a 
very useful technique. Because of their decreased size, they accounted 
for great savings in tissue culture cells, medium and reagents, and the 
plates were easier to handle than the equivalent number of chamber/ 
slides. 
Using microtiter plates does require some precautions. First of 
all, during fixation the acetone must be added carefully to each well 
or the wells may be etched enough that the cells cannot be seen. 
Another problem is that a special long working distance objective 
is needed for the fluorescent microscope. Because such objectives are 
expensive, this generally means interpretations must be made with a 
single objective. These special objectives are also a low magnifica-
tion, such as X20, as the one used in the present study. Although this 
is adequate for scanning, it does create some problems in distinguishing 
between nonspecific and specific staining. .This problem was most ap-
parent at low serum dilutions (or undiluted serum) and at high dilutions 
near to endpoints. Because of this, the useful range of serum dilutions 
in the present study was found to be between 1:10 and 1:640. When com-
parisons were made between chamber/slides and microtiter plates, the mi-
crotiter plate method gave similar results to the chamber/slide method 
within this range of serum dilutions. 
Most of the work with the CF test was disappointing, mainly because 
a suitable antigen to BRSV could not be produced in cell cultures. The 
whole culture antigen, which is used for human RS virus, never gave 
high enough titers to be useful. Further research indicated that the 
CF antigens were intracellular, so efforts were focused on using a cell 
phase antigen. 
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Although the cell phase antigen gave better results, it was anti-
complementary when used with bovine antiserum. It was later decided 
that at least part of this problem was caused by the complement modifier. 
Despite the AC problem, antigen titers of 1:8 or greater did not appear 
to be possible. Since there did not appear to be a solution for these 
problems, work with BRSV antigen was discontinued. Further research 
with cell phase, though, may show this to be an acceptable antigen. 
Since low antigen titers were obtained with both types of antigen 
using RSV antserum, some antigen must have been present. According to 
previous reports, these titers should have been higher using bovine 
antiserum (1,15). Several things may have caused the problems with 
BRSV antigens. The strain of virus, cell line, culture medium, size of 
inoculum, length of incubation and the choice of bovine antiserum may 
all have had an adverse effect on the results. 
Japanese researchers immunized rabbits with BRSV and used their 
sera to determine antigen titers. This is probably a better approach, 
since antibodies to a specific strain of virus are obtained, and the 
complement modifier is not needed with rabbit serum. They also used a 
different strain of virus, cell line and medium, which may explain why 
they could use whole culture antigen (15). 
The CF test, though not as sensitive as the IFA test still indi-
cated high titers and titers of 1:8 or greater were still apparent six-
teen weeks later. The antibody response was more what was originally 
expected in that high titers were reached in about four weeks then 
titers began a steady decline. Also the four calves that were aerosoled 
with BRSV showed more of a secondary antibody response than those calves 
not receiving BRSV. The calves that received BRSV either had a steady 
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titer or an increased titer about five weeks after receiving the virus. 
l·'rorn this it appears that the CF test was more sui table in detecting 
the secondary response, therefore it may be a .better test for detecting 
reinfections than the IFA test. 
The CF test, using RSV antigen, appears to be a useful diagnostic 
tool, especially for those laboratories already familiar with the CF 
test. No one has yet done an extensive comparison of bovine antibody 
titers obtained using both RSV antigen and BRSV antigen. The antibody 
titers obtained using RSV antigens are probably one or two dilutions 
lower than they would be using BRSV antigen. Since RSV antigens are 
available commercially, thus eliminating the need for cell cultures, 
using RSV antigen may be more practical than using BRSV antigens. 
An advantage of the CF test is that it does not require the spe-
cialized and expensive equipment needed for the IFA test. It also has 
its disadvantages. The CF test requires a great deal of experience in 
order to get consistent results, and since exact volumes and titers 
must be determined it is more subject to technical errors. Other prob-
lems are that some sera are anticomplementary even after treatment, and 
that a suitable complement modifier is needed to test bovine serum. 
CHAPTER VI 
SUMMARY 
An IFA method was developed for determining BRSV titers. When 
this method was compared to the MG-G method, it was found to be as sen-
sitive as the MG-G method but titers could be determined 48 hours 
earlier using the IFA method. 
Goat turbinate cells, infected with BRSV, were grown in microtiter 
tissue culture plates and were stained and examined by an IFA technique. 
This method was used to determine the antibody titers of 25 calves 
during a four month period. Antibody titers increased rapidly and 
titers of 1:80 or greater were still present almost four months after 
the initial infection. This rapid antibody response in this age group 
of calves may be significant in determining whether antibodies are of 
maternal or natural origin and the prolonged high titers may create 
problems in determining the exact time of infection. 
Attempts to produce CF antigens to the FSl-1 strain of BRSV were 
unsuccessful. Commercially prepared antigens to. the Long strain of 
human RSV were available and were used to test sera from seven of the 
calves. The CF test was not as sensitive as the IFA method, but anti-
bodies were still detectable at the end of four months. However, the 
CF test appeared to detect a secondary antibody response from four of 
the calves, five weeks after they had been aerosoled with bovine RS 
virus. A secondary response was not apparent from the IFA test results. 
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APPENDIX 
THE C-8 BACTERIN EXPERIMENT 
The serum samples tested were from the 25 calves used in the C~8 
bacterin experiment that was conducted by the Respiratory Disease 
Laboratory. These calves were raised at the Veterinary Research Station 
at Pawhuska, Oklahoma, and were recently weaned calves weighing 400-500 
pounds. The experiment was started November 12, 1975 and ended when 
the calves were slaughtered on March 8 and March 15, 1976. 
The experiment was divided into two phases. The objectives of the 
Pawhuska phase were to study the toxicity of Pasteurella multocida and 
Pasteurella hemolytica and to evaluate different methods of infecting 
calves with these organisms. The calves were divided into four groups, 
and some calves from each group were transported in an open truck while 
the remaining calves served as non-transported controls (Table X). 
Calves to be transported were loaded on an open truck and transported 
for 12 continuous hours, then returned to the station. The initial col-
lection of nasal, tracheal and serum specimens was done at this time 
then the calves were given the treatments shown in Table X. All the 
calves were maintained together on open pasture at the experimental sta-
tion. Specimens were again collected and the treatments repeated on 
November 20, 1975. Additional specimens were collected at weekly inter-
vals throughout the experiment. 
The second phase of the experiment was started by transporting 20 
47 
48 
of these calves to the Veterinary Science area at Stillwater. The ob-
jectives of this phase were to study what effect bovine respiratory 
syncytial virus has, alone or in combination with Pasteurella multocida, 
in bovine respiratory disease. 
The calves were again divided into four groups and given the treat-
ments shown in Table XI. Each group was kept at separate locations in 
the Veterinary Science area. Serum, nasal and tracheal specimens were 
collected at weekly intervals until 14 of the calves were slaughtered 




































10 ml of saline sub-
cutaneous 
5 ml 5964 Bacterin and 
5 ml 6013 Bacterin, 
subcutaneous 
10 ml of saline by 
aerosol 
5 ml 5964 Bacterin and 
5 ml 6013 Bacterin by 
aerosol 
1Bacterin 5964, Pasteurella multocida; Bacterin 6013, Pasteurella 
hemolytica. 
Treatment Schedule: 11-12-75 - Calves transported for 12 hours. 




TREATMENTS GIVEN CALVES IN STILLWATER PROJECT 
Calf No. Group No. Treatments 














Aerosoled with phosphate buffered 
saline (PBS) 
Aerosoled with Bovine RS virus. 
Aerosoled with Bovine RS virus and 
Pasteurella multocida 
1-30-76 Aerosoled groups 1 and 2 with P. multocida. 
2-2-76 Aerosoled groups 3 and 4 with bovine RS virus. 
2-9-76 Aerosoled groups 2 and 4 with PBS: aerosoled groups 1 and 4 
with P. multocida. 
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